Author: Kristen Barton

Kristen Barton is a managing director and co-director of investment research. Kristen is also a senior research analyst focusing on agriculture & biotech companies. Prior to joining Tech Insider in 2010, Barton worked in equity research at RBC Capital Markets in Minneapolis, MN and Edward Jones in St. Louis, Mo. She was recognized for her stock picking in the 2012 Wall Street Journal "Best on the Street" publication.
FB Nasdaq FB Facebook
Finance

Hot Watch List: Plug Power (NASDAQ:PLUG), Companhia Energetica Minas Gerais (NYSE:CIG), FuelCell Energy (NASDAQ:FCEL), SINA (NASDAQ:SINA), Qihoo 360 Technology (NYSE:QIHU)

Plug Power Inc. (NASDAQ:PLUG) on May 14 reported its 2014 first quarter results. Total revenue for the first quarter of 2014 was $5.6 million, comprised of $3.2 million for product revenue, $2.1 million for service revenue and $0.3 million for research and development (R&D) contract revenue. This compares to total revenue of $6.4 million in the first quarter of 2013, which was comprised of $4.7 … Continue reading Hot Watch List: Plug Power (NASDAQ:PLUG), Companhia Energetica Minas Gerais (NYSE:CIG), FuelCell Energy (NASDAQ:FCEL), SINA (NASDAQ:SINA), Qihoo 360 Technology (NYSE:QIHU)

Kristen Barton
Gilead Sciences GILD NASDAQ:GILD
Finance

Hot Biotech Watch List: InterMune Inc (NASDAQ:ITMN), Merrimack Pharmaceuticals (NASDAQ:MACK), China Biologic Products (NASDAQ:CBPO), VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA)

InterMune, Inc. (NASDAQ:ITMN) on 27 May 2014 announced that it has resubmitted its pirfenidone New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in response to a Complete Response Letter (CRL) received in May 2010. Pirfenidone is being developed for the treatment of adult patients with idiopathic pulmonary fibrosis (IPF). InterMune Inc (NASDAQ:ITMN) stock performance was -0.88% in last session and finished … Continue reading Hot Biotech Watch List: InterMune Inc (NASDAQ:ITMN), Merrimack Pharmaceuticals (NASDAQ:MACK), China Biologic Products (NASDAQ:CBPO), VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA)

Kristen Barton
Gilead Sciences GILD NASDAQ:GILD
Finance

Gainers to Watch: Apple Inc. (NASDAQ:AAPL), 58.com Inc (ADR) (NYSE:WUBA), China Mobile Games & Entnmnt (NASDAQ:CMGE), ParkerVision (NASDAQ:PRKR), Imperva (NYSE:IMPV)

Apple Inc (NASDAQ:AAPL) had been in talks about a possible purchase of the stake in Renesas SP Driver in what was seen as a potential move to shore up its global supply chain, but the sources said those talks failed to make progress and Renesas had narrowed its consideration to Synaptics. Apple Inc. (NASDAQ:AAPL) stock performance was 1.87% in last session and finished the day … Continue reading Gainers to Watch: Apple Inc. (NASDAQ:AAPL), 58.com Inc (ADR) (NYSE:WUBA), China Mobile Games & Entnmnt (NASDAQ:CMGE), ParkerVision (NASDAQ:PRKR), Imperva (NYSE:IMPV)

Kristen Barton
Gilead Sciences GILD NASDAQ:GILD
Finance

Consumer Goods Active Movers: Apple Inc. (NASDAQ:AAPL), Ford Motor Company (NYSE:F), General Motors (NYSE:GM), The Coca-Cola (NYSE:KO), Mondelez International (NASDAQ:MDLZ)

Apple Inc (NASDAQ:AAPL) supplier Foxconn Technology Group will buy a stake in Taiwanese mobile telecoms operator Asia Pacific Telecom for T$11.6 billion ($390 million) in a deal that would expand its presence in Taiwan’s fledgling 4G telecoms market. Apple Inc. (NASDAQ:AAPL) stock performance was 1.13% in last session and finished the day at $614.13. Traded volume was 8.29million shares in the last session and the … Continue reading Consumer Goods Active Movers: Apple Inc. (NASDAQ:AAPL), Ford Motor Company (NYSE:F), General Motors (NYSE:GM), The Coca-Cola (NYSE:KO), Mondelez International (NASDAQ:MDLZ)

Kristen Barton
Finance

Notable Movers: ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS), PTC Therapeutics, Inc. (NASDAQ:PTCT), Orexigen Therapeutics, Inc. (NASDAQ:OREX), CytRx Corporation (NASDAQ:CYTR), ZIOPHARM Oncology (NASDAQ:ZIOP)

ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) presented results from a global, multi-center, open-label, comparator-controlled phase II study in patients undergoing total knee replacement surgery or total knee arthroplasty (TKA). Two doses of ISIS-FXIRx (200mg, 300mg) were compared to Sanofi’s Lovenox (enoxaparin). ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) stock performance was 11.26% in last session and finished the day at $27.81. Traded volume was 4,554,523 shares in the last session … Continue reading Notable Movers: ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS), PTC Therapeutics, Inc. (NASDAQ:PTCT), Orexigen Therapeutics, Inc. (NASDAQ:OREX), CytRx Corporation (NASDAQ:CYTR), ZIOPHARM Oncology (NASDAQ:ZIOP)

Kristen Barton
FB Nasdaq FB Facebook
Finance

Watch list: Tesla Motors Inc (NASDAQ:TSLA), Cosi Inc (NASDAQ:COSI), EDAP TMS (NASDAQ:EDAP), Cisco Systems (NASDAQ:CSCO), International Business Machines Corp. (NYSE:IBM)

Tesla Motors Inc (NASDAQ:TSLA) has announced the Australian pricing for its Model S range ahead of its official release date. $95,000 buys you a stock 60kWh Tesla Motors Inc (NASDAQ:TSLA) Model S, which normally costs just over $US81,000 in North America (the additional charge comes from GST, the Luxury Car Tax and Stamp Duty). Tesla Motors Inc (NASDAQ:TSLA) stock performance was 2.72% in last session … Continue reading Watch list: Tesla Motors Inc (NASDAQ:TSLA), Cosi Inc (NASDAQ:COSI), EDAP TMS (NASDAQ:EDAP), Cisco Systems (NASDAQ:CSCO), International Business Machines Corp. (NYSE:IBM)

Kristen Barton